 BALTIMORE, Aug. 19, 2021 GLOBE NEWSWIRE -- Greater Cannabis Company, Inc. GCANRx or the Company OTCQB: GCAN a cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has entered into a licensing agreement the Agreement with Shaare Zedek Scientific Ltd. SZS, the technology transfer arm of Jerusalems Shaare Zedek Medical Center SZMC. The agreement covers the license of SZSs novel cannabinoid therapeutic focused on treatment of autism, schizophrenia, Parkinsons disease, Alzheimers disease and other neuropsychiatric disorders. Shaare Zedek Medical Center, founded in 1901, is one of the largest multidisciplinary research hospitals in Israel with 1,000 beds and over 850,000 patient visits a year. The SZMC Center for Research and Development has over 300 annual publications of investigator initiated studies in medical journals in addition to almost 160 clinical trials. 